Novel Anti-influenza Drugs

  • Author: Melania Tesio
  • Published: 25 April 2013
  • Copyright: Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
  • Source / Publisher: Science/American Association for the Advancement of Science (AAAS)
thumbnail image: Novel Anti-influenza Drugs

Neuraminidase is a sialic acid hydrolase that promotes viral spreading. Widely used anti-influenza drugs, such as zanamivir and oseltamivir, selectively inhibit neuraminidase. Some influenza strains, however, are resistant to these therapies.

To overcome this limitation, Jin-Hyo Kim, University of British Columbia, Canada, and colleagues developed a novel class of drugs. The researchers demonstrated that the reaction catalyzed by the viral neuraminidase involves the formation of a covalent intermediate. This intermediate can be exploited to block the viral replication. Difluorosialic derivatives bearing an equatorial fluorine at C2 and guanine substituents at C4 (such as FeGuDFSA, pictured) stabilized the covalent intermediate and were as efficient as zanamivir in blocking the viral replication.

These compounds, moreover, showed a broad-spectrum activity against viral strains resistant to zanamivir and oseltamivir. Therefore, they represent novel promising anti-influenza drugs.

Article Views: 2906

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

If you would like to reuse any content, in print or online, from, please contact us first for permission and consult our permisson guidance prior to making your request

Follow on Facebook Follow on Twitter Follow on YouTube Follow on LinkedIn Follow on Instagram RSS Sign up for newsletters

Magazine of Chemistry Europe (16 European Chemical Societies) published by Wiley-VCH